Sen. Blumenthal calls on FDA to end shortage of EpiPens
<p>Sen. Richard Blumenthal is calling on the FDA to help end critical shortages of EpiPens and other anti-allergy devices.</p>
•
May 15, 2018, 11:42 AM
•
Updated 2,412 days ago
Share:
Sen. Richard Blumenthal is calling on the FDA to help end critical shortages of EpiPens and other anti-allergy devices.
Last week, the agency announced shortages due to delays at the plant which manufactures the device.
Blumenthal sent a letter to the FDA, pushing for immediate action.
"...EpiPens are a matter of life and death for children... who may be allergic to peanuts or other food," said Blumenthal.
A spokesperson for the FDA tells Bloomberg that they've received Blumenthal's letter and will respond to him directly.
Patients are encouraged to call Mylan's customer relations line for help locating alternate pharmacies.
More from News 12
2:47
BITTER BLAST: Morning snow followed by deep cold in Connecticut
Government funding bill clears Congress and heads to President Biden, averting a shutdown
0:24
Greenwich 3rd grader publishes Christmas-themed comic book
1:28
FDA announces new criteria for what foods can be considered healthy
3:04
Made In Connecticut: Cooking with Master Chocolatier Fritz Knipschildt
2:26
